In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.

In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.

The role of selinexor in early rrMM and sequencing in 2024.

Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases.

Share The role of selinexor in early rrMM and sequencing in 2024.

Sign up to save your podcasts

The role of selinexor in early rrMM and sequencing in 2024.

The role of selinexor in early rrMM and sequencing in 2024.